We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Portable Nucleic Acid Extraction System Developed For POC Diagnostics

By LabMedica International staff writers
Posted on 31 Jul 2013
A portable, pressure driven, room temperature nucleic acid extraction and storage system for point of care (POC) molecular diagnostics has been developed. More...


A minimally instrumented sample preparation technology yields a purified and thermally stabilized nucleic acid sample that eliminates the cold chain without reducing sensitivity or an increase in downstream processing infrastructure.

Biomedical engineers at Boston University (MA, USA) have developed a whole blood compatible, enzyme-free, ambient temperature, low-pressure nucleic acid extraction process that enables the creation of a completely powerless nucleic acid sample preparation technology. This technology will allow, for example human immunodeficiency virus (HIV) viral load monitoring in low resource areas.

A novel hybrid alcohol precipitation and solid phase extraction process has been presented, utilizing glycogen carrier particles to increase the effective hydrodynamic radius of precipitated nucleic acids aggregates, and a thermally polymerized acrylate based solid phase as a weir for analyte capture. An air pressure driven mechanical system was developed to perform this process in a semiautomated fashion, in order to insulate the process from variations in operator technique. Together, they form the System for Nucleic Acid Purification (SNAP).

The portable system for centrifuge-free room temperature nucleic acid extraction from 70 μL of whole blood uses only thermally stable reagents compatible with storage and transport in low resource settings. Quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) analysis of simulated samples demonstrate a lower limit of detection of 1,000 copies per mL, with the ability to detect differences in viral load across four orders of magnitude.

The device weighs less than 1.36 kg and is capable of extracting HIV-1 viral ribonucleic acid (RNA) directly from virions in whole blood in less than 35 minutes. Samples are stabilized on detachable cartridges, which can be eluted either at the point of care, or transported to a centralized laboratory for further analysis. The study was published on May 13, 2013, in the journal Analytical Methods.

Related Links:

Boston University




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The approach uses in-house pathology tests and streamlined access to specialists to shorten the diagnostic pathway for children with immune conditions. (Image Credit: iStock)

Streamlined Genetic Testing Speeds Pediatric Immune Disorder Diagnosis

Children with genetic immune conditions can develop life-threatening illness, unusual infections, or autoimmune problems before the underlying cause is identified. More than 500 of these rare disorders... Read more

Immunology

view channel
Image: Acute myeloid leukemia is the first of several disease areas the collaborators plan to pursue together as part of efforts to advance precision diagnostics (Image Credit: Adobe Stock)

Immune Profiling Initiative Aims to Improve Bone Marrow Analysis in Leukemia

Acute myeloid leukemia (AML) is an aggressive blood cancer in which assessing disease burden after therapy can help guide clinical evaluation. Patients with measurable residual disease (MRD) after treatment... Read more

Industry

view channel
Image: The acquisition of Reveal Genomics would expand Hologic’s oncology diagnostics portfolio to support treatment decisions for more women with breast cancer.

Hologic to Broaden Breast Cancer Testing Portfolio Through Reveal Genomics Acquisition

Hologic (Marlborough, MA, USA) has signed a definitive agreement to acquire Reveal Genomics (Barcelona, Spain), a precision oncology company developing genomic diagnostic tests to help personalize cancer treatment.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.